RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today the appointment of Luis T. Gutierrez, Jr. as Executive Vice President and Chief Commercial Officer. In this role, he will oversee the global Business Development, Proposal Development, Marketing and Brand Management functions at Aptiv Solutions.
Mr. Gutierrez brings over 25 years of industry operational and business development experience to Aptiv Solutions including significant senior tenure with Merck, Covance, and, most recently, MedAssurant, where he served as the Senior Vice President of Pharmaceutical and Life Sciences Operations. Prior to that, he was with Covance for over 19 years where he advanced through the ranks, assuming commercial leadership positions of progressively greater responsibility. Mr. Gutierrez ultimately served as President, Periapproval and Market Access Services at Covance, where he also was an integral member of Covance’s Global Leadership Council. Prior to joining Covance in 1991, Mr. Gutierrez worked in Business Development with Merck & Company. Mr. Gutierrez received a bachelor of arts, with honors, from Harvard University and a master of business administration degree from Stanford University's Graduate School of Business.
“I’m extremely pleased to have Luis join our growing company as part of the senior management team,” said Patrick K. Donnelly, Chairman and CEO at Aptiv Solutions, “He brings a depth and breadth of experience that adds to the already outstanding executive leadership team we have in place. With this appointment, Aptiv Solutions continues to add talented staff to help our clients in the design and execution of adaptive clinical trials and medical device development.”
Mr. Gutierrez added, “I am thrilled to be joining Aptiv Solutions at a time when both regulators and sponsors are becoming increasingly enthusiastic about adaptive clinical trials and are changing requirements for medical device approvals. Aptiv Solutions is uniquely positioned to assist clients in addressing both of these changes and I look forward to further building our market presence as the leading provider of adaptive trial design, execution and clinical trial services.”
About Aptiv Solutions
Aptiv Solutions is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market. The company offers clients an extensive portfolio of innovative services including adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing and the operational support of a global clinical research organization. Aptiv Solutions has over 850 professionals in North America, Europe, the Middle East, Japan, and Australia. Visit the website at www.aptivsolutions.com.